In conclusion, our results propose that GSK3B and galectin-3 are involved in important molecular changes that are significantly related to the WHO astrocytoma grade and are independent biomarkers for astrocytoma prognosis. The gene discussed is LGALS3; the disease is astrocytoma (excluding glioblastoma).